Sarhan, A. S., & Naji, A. S. (2026). Clinical Outcomes and Safety of Pembrolizumab Monotherapy in Iraqi Patients with Metastatic Lung Cancer and Renal Cell Carcinoma. Middle Eastern Cancer and Oncology Journal, 2(2), 59–66. https://doi.org/10.61706/MECOJ160228